Hematology/Oncology

Top Story

AMA, Mayo Clinic working to create ‘medical school of the future’

March 29, 2017

The AMA and the Mayo Clinic recently convened its 32-school Accelerating Change in Medical Education Consortium to develop innovative ideas regarding physician training, according to an AMA press release.

The Mayo Clinic School of Medicine’s first class of medical students at its new Scottsdale campus will use the curriculum models being developed by the consortium.

FDA News

FDA grants priority review to CTL019 for ALL

March 29, 2017
The FDA granted priority review to tisagenlecleucel-T, an investigative chimeric antigen receptor T-cell therapy intended for children and young adults with relapsed and…
In the Journals Plus

Use of prophylactic mastectomy increasing among younger women with early-stage breast cancer

March 29, 2017
More than one-third of women aged 20 to 44 years who underwent surgery for invasive unilateral breast cancer elected to remove the unaffected breast for preventive…
FDA News

FDA advisory committee recommends Rituxan coformulation for blood cancers

March 29, 2017
An FDA advisory committee unanimously recommended approval of subcutaneous rituximab plus hyaluronidase for the treatment of several blood cancers. The advisory…

USC researcher awarded grant to study link between GERD, esophageal cancer

March 29, 2017
The DeGregorio Family Foundation and the Price Family Foundation have awarded a $175,000 grant to Anisa Shaker, MD, assistant professor of medicine at the Keck School…
More News Headlines »
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Video
Meeting News

VIDEO: Artificial intelligence may be feasible for melanoma diagnosis

March 24, 2017
More »
Featured
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies

CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement